Spotlight/ Conversations COO Reflects on the Challenges and Path of His Journey Date published: March 5, 2025 9:00 am PST Share Copied! Tu Diep, Skye Bioscience’s COO discusses his lifelong passion, interest and work leading up to the clinical drug development journey of lead asset nimacimab.